Observed Signal · Oct 13, 2026 · corporate_event · Source: SEC API · Impact: 3.2/5
8-K/A Financial Filing Analysis for Clarivate (2026-10-13)
Clarivate Plc filed a Form 8-K/A amendment to provide required unaudited pro forma financial statements following the completion of the sale of its Life Sciences and Healthcare business on October 6, 2026. This amendment incorporates pro forma condensed consolidated balance sheets as of June 30, 2026, alongside pro forma condensed consolidated statements of operations for the six months ended June 30, 2026, and the fiscal years ended December 31, 2025, 2024, and 2023. The filing satisfies SEC reporting requirements under Item 9.01 following the divestiture, providing baseline historical financial context for the company's remaining operations.
This amendment finalizes the regulatory disclosure requirements for the completed divestiture of Clarivate's Life Sciences and Healthcare unit, allowing investors to evaluate the remaining core IP and workflow software business.
Track Clarivate Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Clarivate completed the sale of its Life Sciences and Healthcare business on October 6, 2026.
- Form 8-K/A amends the original filing to provide required pro forma financial statements under Exhibit 99.1 within four business days.
- Pro forma condensed consolidated financial statements cover the balance sheet as of June 30, 2026, and statements of operations for H1 2026 and FY 2023–2025.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
8-K/A Financial Filing Analysis for JCDecaux (2026-09-18)
Diversified Energy Company filed Form 8-K/A to provide the required historical audited and unaudited financial statements as well as unaudited pro forma condensed combined financial information related to its acquisition of 100% of the equity interests in certain affiliates of Camino Natural Resources, LLC. The underlying assets include oil and natural gas wells, leasehold interests, and undeveloped acreage situated in Oklahoma. This filing fulfills SEC reporting obligations under Item 9.01 following the completion of the transaction originally reported on July 6, 2026.
8-K Financial Filing Analysis for Harmonic (2026-08-12)
On August 12, 2026, Harmonic Inc. submitted a Form 8-K under Item 2.02 to announce its preliminary unaudited financial results for the second quarter ended July 3, 2026. The company furnished its earnings press release as Exhibit 99.1 and conducted an accompanying investor conference call on the same date. Because the actual earnings figures and financial tables were furnished via Exhibit 99.1 rather than directly embedded in the body of the Form 8-K, the filing serves as a procedural disclosure notifying the market of the availability of its Q2 2026 operating results.
8-K Financial Filing Analysis for Okta (2026-08-26)
On August 26, 2026, Okta, Inc. submitted a Form 8-K under Item 2.02 furnishing a press release that announced its financial results for the fiscal quarter ended July 31, 2026. The full operational metrics, income statement details, and forward-looking commentary were provided via Exhibit 99.1, which is furnished rather than filed under Section 18 of the Securities Exchange Act of 1934. The filing serves as the regulatory notice of Okta's quarterly earnings release signed by Chief Financial Officer Brett Tighe.
Receive all future signals for Clarivate & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.